Page contentsPage contents Key facts Decision Key facts Active substance nitrous oxide Therapeutic area Pain Decision number P/0217/2018 PIP number EMEA-002340-PIP01-18 Pharmaceutical form(s) Medicinal gas (liquefied) Condition(s) / indication(s) Sedation Route(s) of administration Inhalation use Contact for public enquiries Società Italiana Carburo Ossigeno Spa SICO Tel. +39 0382530059 E-mail: regulatory@gbpharma.it, cvino@gbpharma.it Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 19/07/2018 Compliance check done No Decision P/0217/2018: EMA decision of 19 July 2018 on the granting of a product specific waiver for nitrous oxide (EMEA-002340-PIP01-18)Adopted Reference Number: EMA/421241/2018 English (EN) (73.91 KB - PDF)First published: 28/11/2018 View Share this page